Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research by a team at the University of Oxford and the NIHR Oxford Biomedical Research Centre and published today in The Lancet provides robust basis for informed shared decision-making and consent on keyhole knee surgery.

An innovative study using 20 years’ worth of data covering around 700,000 arthroscopic partial meniscectomies (APM), or keyhole knee surgery, looked at the risks from the procedure when compared to the general population, to inform the conversations between clinicians and patients affected by meniscal tears.

More than 30% of people over 50 have meniscal problems, rising to over 60% for individuals with osteoarthritis (OA). APM is one of the most commonly performed orthopaedic procedures worldwide for these problems and recent research has raised concerns both about its effectiveness and potential for complications.

Our findings enable patients and clinicians to understand, for the first time, the true risk that can be attributed to undergoing this common surgical procedure.
- Simon Abram

The Oxford team has shown that whilst very rare, serious complications such as pulmonary embolism and infection can arise following APM, which should limit the procedure to carefully selected patients.

Professor Andrew Price, lead investigator on the project and president of the British Association for Surgery of the Knee says: “We have recently made great steps forward in understanding who will benefit from arthroscopic meniscal surgery. It’s also critical to assess the potential risks of these procedures. Our aim was to improve information available for patients and clinicians to enhance the shared decision making process."

The research looked at around 700,000 procedures in England using data from the National Health Service and Office for National Statistics databases in England for the last 20 years. In addition to the volume of data, the team took an innovative approach to data analysis.

“By comparing the rate of each potential adverse outcome occurring following APM with the frequency of that outcome occurring in the general population, our findings enable patients and clinicians to understand, for the first time, the true risk that can be attributed to undergoing this common surgical procedure”, adds Simon Abram, first author of the paper published today.

Shared decision-making is an important aspect of improving healthcare in the NHS, where patients and clinicians work together to decide on treatments and approaches which best suit an individual’s circumstances. This process puts people at the heart of decisions about their own care, empowering patients and carers and fostering meaningful conversations with the health professionals involved.

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.